Johan Renes is a qualified European patent attorney and provides general boardroom consultancy services to international clients in the life sciences sector. He has extensive experience in patent litigation and IP portfolio management, as well financing and IPOs in the biotech sector. His clients range from big pharma to series B startups, as well as non-governmental organisations and universities. He has been involved in international litigation from the late 1980s on antibodies, antisense RNA, therapeutic proteins, PCR and pharmaceutical small molecules.